You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Hospira Inc., A Pfizer Company Company Profile


✉ Email this page to a colleague

« Back to Dashboard


Summary for Hospira Inc., A Pfizer Company
Patents:0
Tradenames:3
Ingredients:3
BLAs:3

Biologic Drugs for Hospira Inc., A Pfizer Company

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Patent Expiration
Hospira Inc., A Pfizer Company RETACRIT epoetin alfa-epbx Injection 125545 2018-05-15 ⤷  Try a Trial
Hospira Inc., A Pfizer Company NIVESTYM filgrastim-aafi Injection 761080 2018-07-20 ⤷  Try a Trial
Hospira Inc., A Pfizer Company NYVEPRIA pegfilgrastim-apgf Injection 761111 2020-06-10 ⤷  Try a Trial
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.